A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
Despite availability of several antiepileptic drugs (AEDs), in one-third of patients,
epilepsy remains uncontrolled with AEDs. There is a need to develop new approaches to improve
the existing medications to relieve patients' epilepsy, and OPC-214870 is being studied for
this purpose.
Phase:
Phase 1
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.